Vineti

Vineti is a biotechnology and enterprise software company founded in 2016 with its headquarters in the United States. The company's slogan, "Vineti’s Personalized Therapy Management (PTM®) drives and scales advanced therapies," is a testament to its focus on providing personalized therapy solutions.

The company offers a proven software platform for cell and gene therapy supply chain management, addressing the challenges faced by biotech and pharmaceutical innovators in developing personalized therapies. Vineti's Personalized Therapy Management (PTM®) platform is designed to drive and scale global personalized therapies, including cell therapies, gene therapies, and cancer vaccines.

Vineti's last investment of $33.00M was made in a Series C round on 13 October 2020, with participation from prominent investors such as Canaan Partners, Casdin Capital, Threshold Ventures, Cardinal Health, LifeForce Capital, McKesson Ventures, Section 32, Novartis Pharma, and Marc Benioff. This significant investment highlights the confidence and support from a diverse group of leading investors in Vineti's innovative solutions for personalized therapy management.